Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma
Clinical trial NCT02474563 · COMPLETED
Trial details
- NCT number
- NCT02474563
- Sponsor
- Janssen Korea, Ltd., Korea
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-05-01
- Primary completion
- 2014-05-01
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.